Metastatic lymph nodes in urogenital cancers: Contribution of imaging findings

Abdominal Imaging

Volumn 31, Issue 5, 2006, Pages 620-629

  Morisawa, N ^a,b   Koyama, T ^c   Togashi, K ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL HOSPITAL ORGANIZATION KYOTO MEDICAL CENTER   (Japan)

^c KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

Computed tomography; Diagnosis; Lymph nodes; Magnetic resonance imaging; Metastases; Urogenital cancers

Indexed keywords

ANTINEOPLASTIC AGENT; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ACCURACY; ARTICLE; BLADDER CANCER; CANCER CHEMOTHERAPY; CANCER PATIENT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; HUMAN; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; LYMPHADENOPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; RADIODIAGNOSIS; STATISTICAL SIGNIFICANCE; TESTIS CANCER; TREATMENT INDICATION; UROGENITAL TRACT CANCER;

HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; UROGENITAL NEOPLASMS;

EID: 33847621178     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-005-0244-5     Document Type: Article

References (45)

1. Mickisch G, Carballido J, Hellsten S, et al. (2001) Guidelines on renal cell cancer. Eur Urol 40:252-255
2. Choyke PL, Amis ES, Bigongiari LR, et al. (2000) Renal cell carcinoma staging. American College of Radiology. ACR appropriateness criteria. Radiology 215(suppl):721-725
3. Oosterlinck W, Solsona E, Van der Meijden APM, et al. (2004) EAU guidelines on diagnosis and treatment of upper urinary tract transitional cell carcinoma. Eur Urol 46:147-154
4. Oosterlinck W, Lobel B, Jaske G, et al. (2002) Guidelines on bladder cancer. Eur Urol 41:105-112
5. Laguna MP, Pizzocaro G, Klepp O, et al. (2001) EAU guidelines on testicular cancer. Eur Urol 40:102-110
6. Schmoll HJ, Souchon R, Krege S, et al. (2004) European consensus on diagnosis and treatment of germ cell cancer: a report of the European Germ Cell Cancer Consensus Group (EGCCCG). Ann Oncol 15:1377-1399
7. Scherr D, Swindle PW, Scardino PT. (2003) National comprehensive cancer network guidelines for the management of prostate cancer. Urology 61(suppl 2A):14-24
8. Harisinghani MG, Dixon WT, Saksena MA, et al. (2004) MR lymphangiography: imaging strategies to optimize the imaging of lymph nodes with ferumoxtran-10. Radiographics 24:867-878
9. Hofer C, Kübler H, Hartung R, et al. (2001) Diagnosis and monitoring of urological tumors using positron emission tomography. Eur Urol 40:481-487
10. Schöder H, Larson SM (2004) Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 34:274-292
11. Grubnic S, Vinnicombe SJ, Norman AR, et al. (2002) MR evaluation of normal retroperitoneal and pelvic lymph nodes. Clin Radiol 57:193-200
12. Kim SH, Kim SC, Choi BI, et al. (1994) Uterine cervical carcinoma: evaluation of pelvic lymph node metastasis with MR imaging. Radiology 190:807-811
13. Van den Brekel MWM, Stel HV, Castelijns JA, et al. (1990) Cervical lymph node metastasis: assessment of radiologic criteria. Radiology 177:379-384
14. Jager GJ, Barentz JO, Oosterhof GO, et al. (1996) Pelvic adenopathy in prostatic and urinary bladder carcinoma: MR imaging with a three-dimensional T1-weighted magnetization-prepared-rapid gradient-echo sequence. AJR 167:1503-1507
15. Harisinghani MG, Barentsz J, Hahn PF, et al. (2003) Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. N Engl J Med 348:2491-2499
16. Deserno WMLLG, Harisinghani MG, Taupitz M, et al. (2004) Urinary bladder cancer: preoperative nodal staging with ferumox-tran-10-enhanced MR imaging. Radiology 233:449-456
17. Dorfman RE, Alpern MB, Gross BH, et al. (1991) Upper abdominal lymph nodes: criteria for normal size determined with CT. Radiology 180:319-322
18. Vinnicombe SJ, Norman AR, Nicolson V, et al. (1995) Normal pelvic lymph nodes: evaluation with CT after bipedal lymphangiography. Radiology 194:349-355
19. Bellin MF, Lebleu L, Meric JB, et al. (2003) Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR lymphangiography. Abdom Imaging 28:155-163
20. Vassallo P, Wernecke K, Roos N, et al. (1992) Differentiation of benign from malignant superficial lymphadenopathy: the role of high-resolution US. Radiology 183:215-220
21. Som PM (1992) Detection of metastasis in cervical lymph nodes: CT and MR criteria and differential diagnosis. AJR 158:961-969
22. Barentz JO, Jager GJ, Van Vierzen PBJ, et al. (1996) Staging urinary bladder cancer after transurethral biopsy: value of fast dynamic contrast-enhanced MR imaging. Radiology 201:185-193
23. Anzai Y, Piccoli CW, Outwater EK, et al. (2003) Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology 228:777-788
24. Motzer RJ, Bander NH, Nanus DM (1996) Renal-cell carcinoma. N Engl J Med 335:865-875
25. Lam JS, Shvarts OS, Leppert JT, et al. (2005) Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 173:1853-1862
26. Hilton S. (2000) Imaging of renal cell carcinoma. Semin Oncol 27:150-159
27. Heidenreich A, Ravery V (2004) Preoperative imaging in renal cell cancer. World J Urol 22:307-315
28. Studer UE, Scherz S, Scheidegger J, et al. (1990) Enlargement of regional lymph nodes in renal cell carcinoma is often not due to metastases. J Urol 144:243-245
29. Johnson CD, Dunnick NR, Cohan RH, et al. (1987) Renal adenocarcinoma: CT staging of 100 tumors. AJR 148:59-63
30. Ozsahin M, Zouhair A, Villa S, et al. (1999) Prognostic factors in urothelial renal pelvis and ureter tumours: a multicentre Rare Cancer Network study. Eur J Cancer 35:738-743
31. Millán-Rodríguez F, Palou J, De la Torre-Holguera P, et al. (1999) Conventional CT signs in staging transitional cell tumors of the upper urinary tract. Eur Urol 35:318-322
32. Leissner J, Hohenfellner R, Thüroff JW, et al. (2000) Lymphadenectomy in patients with transitional cell carcinoma of the urinary bladder; significance for staging and prognosis. Br J Urol 85:817-823
33. Mills RD, Turner WH, Fleischmann A, et al. (2001) Pelvic lymph node metastases from bladder cancer: outcome in 83 patients after radical cystectomy and pelvic lymphadenectomy. J Urol 166:19-23
34. Abdel-Latif M, Abol-Enein H, El-Baz M, et al. (2004) Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 172:85-89
35. Koss JC, Arger PH, Coleman BG, et al. (1981) CT staging of bladder carcinoma. AJR 137:359-362
36. Vock P, Haertel M, Fuchs WA, et al. (1982) Computed tomography in staging of carcinoma of the urinary bladder. Br J Urol 54:158-163
37. Tanimoto A, Yuasa Y, Imai Y, et al. (1992) Bladder tumor staging: comparison of conventional and Gadolinium-enhanced dynamic MR imaging and CT. Radiology 185:741-747
38. Narumi Y, Kadota T, Inoue E, et al. (1993) Bladder tumors: staging with gadolinium-enhanced oblique MR imaging. Radiology 187:145-150
39. Hilton S, Herr HW, Teitcher JB, et al. (1997) CT detection of retroperitoneal lymph node metastases in patients with clinical stage I testicular nonseminomatous germ cell cancer: assessment of size and distribution criteria. AJR 169:521-525
40. Steyerberg EW, Vergouwe Y, Keizer HJ, et al. (2001) Residual mass histology in testicular cancer: development and validation of a clinical prediction rule. Stat Med 20:3847-3859
41. Cremerius U, Effert PJ, Adam G, et al. (1998) FDG PET for detection and therapy control of metastatic germ cell tumor. J Nucl Med 39:815-822
42. Partin AW, Mangold LA, Lamm DM, et al. (2001) Contemporary update of prostate cancer staging nomograms (Partin tables) for the new millennium. Urology 58:843-848
43. Spencer J, Golding S (1992) CT evaluation of lymph node status at presentation of prostatic carcinoma. Br J Radiol 65:199-201
44. Oyen R, Van Poppel HP, Ameye FE, et al. (1994) Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients. Radiology 190:315-322
45. Wolf JS, Cher M, Dall'era M, et al. (1995) The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol 153:993-999